Free Trial
NASDAQ:NXGL

NexGel Q2 2025 Earnings Report

NexGel logo
$2.66 +0.03 (+0.95%)
As of 01:41 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NexGel EPS Results

Actual EPS
N/A
Consensus EPS
-$0.07
Beat/Miss
N/A
One Year Ago EPS
N/A

NexGel Revenue Results

Actual Revenue
N/A
Expected Revenue
$3.08 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

NexGel Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Tuesday, August 12, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

NexGel Earnings Headlines

Altucher: Trump’s Great Gain is starting
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.
See More NexGel Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NexGel? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NexGel and other key companies, straight to your email.

About NexGel

NexGel (NASDAQ:NXGL) manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

View NexGel Profile

More Earnings Resources from MarketBeat